Found: 85
Select item for more details and to access through your institution.
Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: A report from the National Cardiovascular Data Registry.
- Published in:
- Catheterization & Cardiovascular Interventions, 2014, v. 83, n. 2, p. 171, doi. 10.1002/ccd.25108
- By:
- Publication type:
- Article
Alabama Coronary Artery Bypass Grafting Project.
- Published in:
- JAMA: Journal of the American Medical Association, 2001, v. 285, n. 23, p. 3003, doi. 10.1001/jama.285.23.3003
- By:
- Publication type:
- Article
Integrating randomized and observational studies to estimate optimal dynamic treatment regimes.
- Published in:
- Biometrics, 2024, v. 80, n. 2, p. 1, doi. 10.1093/biomtc/ujae046
- By:
- Publication type:
- Article
A Generalized Estimator of the Attributable Benefit of an Optimal Treatment Regime.
- Published in:
- Biometrics, 2010, v. 66, n. 2, p. 512, doi. 10.1111/j.1541-0420.2009.01282.x
- By:
- Publication type:
- Article
Utilizing Propensity Scores to Estimate Causal Treatment Effects with Censored Time-Lagged Data.
- Published in:
- Biometrics, 2001, v. 57, n. 4, p. 1207, doi. 10.1111/j.0006-341X.2001.01207.x
- By:
- Publication type:
- Article
TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 508, doi. 10.1164/rccm.202312-2224LE
- By:
- Publication type:
- Article
Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
TOLLIP, MUC5B and the Response to N-acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 12, p. E1, doi. 10.1164/rccm.201505-1010oc
- By:
- Publication type:
- Article
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.
- Published in:
- Respiratory Research, 2013, v. 14, n. 7, p. 1, doi. 10.1186/1465-9921-14-73
- By:
- Publication type:
- Article
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2015, v. 26, n. 2, p. 151, doi. 10.1111/jce.12567
- By:
- Publication type:
- Article
Optimal Timing of Implantable Cardioverter-Defibrillator Implantation After Myocardial Infarction: A Decision Analysis.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2010, v. 21, n. 7, p. 791, doi. 10.1111/j.1540-8167.2009.01696.x
- By:
- Publication type:
- Article
Edetate Disodium–Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 10, p. 794, doi. 10.1001/jama.2024.11463
- By:
- Publication type:
- Article
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 4, p. 328, doi. 10.1001/jama.2023.11043
- By:
- Publication type:
- Article
Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Implementation of a Statewide System for Coronary Reperfusion for ST-Segment Elevation Myocardial Infarction.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 20, p. 2371, doi. 10.1001/jama.298.20.joc70124
- By:
- Publication type:
- Article
Clopidogrel and Long-term Outcomes After Drug-Eluting Stent Implantation.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 2, p. 159, doi. 10.1001/jama.297.2.joc60179
- By:
- Publication type:
- Article
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 24, p. 3012, doi. 10.1001/jama.293.24.3012
- By:
- Publication type:
- Article
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The Progression of Fenfluramine-Associated Valvular Heart Disease Assessed by Echocardiography.
- Published in:
- Annals of Internal Medicine, 2001, v. 134, n. 4, p. 261, doi. 10.7326/0003-4819-134-4-200102200-00008
- By:
- Publication type:
- Article
Economic Assessment of Thrombocytopenia: CATCH Registry.
- Published in:
- Journal of Medical Systems, 2010, v. 34, n. 3, p. 379, doi. 10.1007/s10916-008-9250-9
- By:
- Publication type:
- Article
Assessing the Economic Attractiveness of Coronary Artery Revascularization in Chronic Kidney Disease Patients.
- Published in:
- Journal of Medical Systems, 2009, v. 33, n. 4, p. 287, doi. 10.1007/s10916-008-9190-4
- By:
- Publication type:
- Article
Outcomes of Second Revascularization Procedures after Stent Implantation.
- Published in:
- Journal of Medical Systems, 2008, v. 32, n. 2, p. 177, doi. 10.1007/s10916-007-9120-x
- By:
- Publication type:
- Article
Cost-effectiveness of imatinib versus interferon-a plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemiaSee accompanying article on pages 258492, this issue.Portions of this study were presented at the 44th Annual Meeting of the American Society for Hematology, December 610, 2002, Philadelphia, Pennsylvania, and at the 45th Annual Meeting of the American Society for Hematology, December 69, 2003, San Diego, California.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 11, p. 2574, doi. 10.1002/cncr.20694
- By:
- Publication type:
- Article
Long-term survival estimates for imatinib versus interferon-a plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemiaPortions of this work were presented at the 39th Annual Meeting of the American Society of Clinical Oncology, May 31June 3, 2003, Chicago, Illinois.See accompanying article on pages 257483, this issue.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 11, p. 2584, doi. 10.1002/cncr.20674
- By:
- Publication type:
- Article
On‐treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post‐hoc analysis of TRANSFORM‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1518, doi. 10.1002/ejhf.3293
- By:
- Publication type:
- Article
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2029, doi. 10.1002/ejhf.2720
- By:
- Publication type:
- Article
Defining changes in physical limitation from the patient perspective: insights from the VITALITY‐HFpEF randomized trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 843, doi. 10.1002/ejhf.2481
- By:
- Publication type:
- Article
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 782, doi. 10.1002/ejhf.2468
- By:
- Publication type:
- Article
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 8, p. 1313, doi. 10.1002/ejhf.2221
- By:
- Publication type:
- Article
Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-α Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia.
- Published in:
- PharmacoEconomics, 2008, v. 26, n. 5, p. 435, doi. 10.2165/00019053-200826050-00007
- By:
- Publication type:
- Article
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Future Directions in Idiopathic Pulmonary Fibrosis Research An NHLBI Workshop Report.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2014, v. 189, n. 2, p. 214, doi. 10.1164/rccm.201306-1141WS
- By:
- Publication type:
- Article
Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Primary Endpoints in Phase 3 Clinical Trials in Idiopathic Pulmonary Fibrosis: One Step at a Time.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 187, n. 11, p. 1271, doi. 10.1164/rccm.201209-1755le
- By:
- Publication type:
- Article
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 186, n. 1, p. 88, doi. 10.1164/rccm.201202-0314OC
- By:
- Publication type:
- Article
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 185, n. 10, p. 1044, doi. 10.1164/rccm.201201-0006pp
- By:
- Publication type:
- Article
Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY‐HFpEF trial.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 1, p. 293, doi. 10.1002/ehf2.14572
- By:
- Publication type:
- Article
Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 1, p. 43, doi. 10.1002/clc.23286
- By:
- Publication type:
- Article
Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 1, p. 38, doi. 10.1002/clc.22603
- By:
- Publication type:
- Article
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 3, p. 1, doi. 10.1161/JAHA.122.027871
- By:
- Publication type:
- Article